Literature DB >> 950490

Production of epidermal acantholysis in normal human skin in vitro by the IgG fraction from pemphigus serum.

J R Schiltz, B Michel.   

Abstract

Normal human skin was maintained in organ cultures for several days in Ham's F-10 medium with good preservation of the epidermal cells. When the partially purified IgG fraction from the pooled sera of patients with pemphigus vulgaris or pemphigus foliaceous was added to this culture system, after 24 hr some evidence of epidermal acantholysis was seen. By 72 hr, extensive suprabasilar epidermal acantholysis had occurred in which the acantholytic cells were indistinguishable histologically from the acantholytic cells in biopsies from skin lesions of patients with pemphigus vulgaris. In the control cultures (i.e., F-10 medium or F-10 medium + normal human serum IgG), none of these changes was seen. Direct immunofluorescent staining of these explants using fluorescein-labeled goat antihuman IgG showed that by 6 hr binding of the pemphigus IgG had occurred in the intercellular cement substance of the epidermis. The staining intensity was maximal by 18 to 20 hr. When the pemphigus serum was fractionated by DEAE-cellulose column chromatography, three major IgG-containing peaks (presumably IgG) were eluted which bound to the epidermoid intercellular substance and caused acantholysis in culture. The complement system did not play a role in the antibody-induced acantholysis since complement was not included in this system and heating the reconstituted F-10 + pemphigus IgG for 1 hr at 58 degrees C did not destroy the acantholytic activity. Autoradiographic experiments showed that after about 2 days in culture the rates of incorporation of RNA and protein precursors in the suprabasilar cells in the presence of pemphigus IgG were reduced to less than 10% of the normal IgG controls, whereas these synthetic activities of the basal cells were only slightly affected. These observations lead to the proposal that it is the interaction of the pemphigus autoantibody(s) with the suprabasilar epidermal cell which initiates and possibly substains the process(es) of acantholysis.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950490     DOI: 10.1111/1523-1747.ep12513454

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  45 in total

Review 1.  Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases.

Authors:  J R Stanley
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

2.  Update on the cloning of monoclonal anti-desmoglein antibodies from human pemphigus patients: implications for targeted therapy.

Authors:  John R Stanley; Ken Ishii; Don L Siegel; Aimee S Payne
Journal:  Vet Dermatol       Date:  2009-10       Impact factor: 1.589

3.  Homologous regions of autoantibody heavy chain complementarity-determining region 3 (H-CDR3) in patients with pemphigus cause pathogenicity.

Authors:  Jun Yamagami; Aimee S Payne; Stephen Kacir; Ken Ishii; Don L Siegel; John R Stanley
Journal:  J Clin Invest       Date:  2010-10-18       Impact factor: 14.808

4.  Protective effect of intravenous immunoglobulin (IVIG) in an experimental model of pemphigus vulgaris.

Authors:  D Mimouni; M Blank; L Ashkenazi; Y Milner; M Frusic-Zlotkin; G J Anhalt; M David; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

5.  Pemphigus antibodies identify a cell surface glycoprotein synthesized by human and mouse keratinocytes.

Authors:  J R Stanley; M Yaar; P Hawley-Nelson; S I Katz
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

6.  Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice.

Authors:  M Amagai; T Nishikawa; H C Nousari; G J Anhalt; T Hashimoto
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

7.  Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study.

Authors:  H Dobrev; L Popova; D Vlashev
Journal:  Arch Dermatol Res       Date:  1996-10       Impact factor: 3.017

8.  Distinction between epidermal antigens binding pemphigus vulgaris and pemphigus foliaceus autoantibodies.

Authors:  J R Stanley; L Koulu; C Thivolet
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

9.  Experimental human cell and tissue models of pemphigus.

Authors:  Gerda van der Wier; Hendri H Pas; Marcel F Jonkman
Journal:  Dermatol Res Pract       Date:  2010-05-26

10.  Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris.

Authors:  Ralf Müller; Nicolas Hunzelmann; Vera Baur; Guido Siebenhaar; Elke Wenzel; Rüdiger Eming; Andrea Niedermeier; Philippe Musette; Pascal Joly; Michael Hertl
Journal:  Dermatol Res Pract       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.